Jane Street Group, LLC Repligen Corp Transaction History
Jane Street Group, LLC
- $445 Billion
- Q3 2024
A detailed history of Jane Street Group, LLC transactions in Repligen Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 74,213 shares of RGEN stock, worth $12.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,213
Previous 127,205
41.66%
Holding current value
$12.3 Million
Previous $16 Million
31.13%
% of portfolio
0.0%
Previous 0.02%
Shares
24 transactions
Others Institutions Holding RGEN
# of Institutions
479Shares Held
54.5MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.26 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$1.06 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$838 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$270 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$236 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $9.22B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....